[MD Fact] SC301 Clinic's 'VBA Stem Cell Breast Augmentation' Becomes a Hot Topic

The VBA breast augmentation recently introduced by SC301 Clinic is attracting attention. VBA breast augmentation is a procedure that fully incorporates the 10 years of stem cell breast augmentation know-how of Dr. Shin Dong-jin, the representative director of SC301 Clinic. It boasts high patient satisfaction as it is performed based on an accurate diagnosis that considers not only volume and balance but also the individual's breast age.

Unlike conventional breast augmentation surgery that involves inserting standardized implants, Viva Breast Augmentation is performed after accurately assessing the current condition of the breasts. It increases volume by injecting the appropriate amount of a blend of stem cells and pure fat in optimal proportions. By conducting pre-operative condition management to prepare the body for optimal fat extraction, the surgery is performed, significantly addressing the issues of low engraftment rates and side effects associated with existing pseudo-stem cell surgeries.

This allows for the creation of breasts that fit the individual's body. Furthermore, it raises the engraftment survival rate from the 10–20% of conventional autologous fat breast augmentation to the 76% range, enabling the volume to be maintained for a long time. This engraftment survival rate is a result proven by Dr. Shin Dong-jin through three published papers.

Director Shin pointed out, “Currently, the number of hospitals performing stem cell breast augmentation is on the rise,” adding, “However, it is no exaggeration to say that there are virtually no places equipped with proper stem cell extraction equipment, medical staff with extensive surgical experience, and systematized personnel.”
He added, “For example, in the case of HuriCell, a stem cell extraction device, the supply of consumables has been discontinued since early 2015, making it unusable, yet there are still quite a few hospitals promoting that they ‘perform surgery with HuriCell.’”

He said, “Above all, the problem is that inexperienced medical staff are performing surgeries and engaging in false and exaggerated advertising by touting unproven engraftment rates of 80–90%.” He added, “In fact, among the patients who visit, there are many who inquire about revision surgery after being dissatisfied or experiencing side effects from procedures performed at other hospitals,” and “It is unfortunate that in such cases, revision surgery is often impossible because the fat available for suction has already been consumed.”

Director Shin advised that one should carefully select a hospital considering these circumstances. He explained, “When planning to undergo stem cell breast augmentation, the most important thing is to properly assess one’s current condition.” He added, “You must find a place that provides a comprehensive plan, ranging from pre-operative care based on an accurate diagnosis by the medical team, to proper stem cell surgery, and post-operative care to maintain long-term satisfaction.”

He further emphasized, “SC301 Clinic follows a three-step process that includes patented pre-operative care perfected with over 10 years of know-how, surgery using the latest stem cell extraction equipment TGI, and post-operative care to increase engraftment rates, so patients can expect highly satisfactory surgical results without side effects with just the first surgery.”

SC301 Clinic has marked the first anniversary of its expansion and relocation from Apgujeong-dong, Gangnam-gu, Seoul to Samseong-dong. With the move, the clinic has equipped itself with a more spacious and comfortable sterile operating room, a stem cell research institute, and convenient patient flow and service systems.

In recognition of these efforts, the hospital received the Minister of Health and Welfare Award in 2014 and the Commissioner of the Food and Drug Safety Award in 2015. A hospital official stated, “We will expand our services to include OB/GYN and dermatology in addition to our existing clinic services, aiming to become a beauty medical group.”

Reporting by Jung Hee-won, MD Fact Reporter md@mdfact.com

The content of this article may not align with the editorial direction of Donga.com.

Original article: http://health.donga.com/List/3/100501/20160106/75765592/2